Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast and accurate detection of 11 clinically relevant gastrointestinal (GI) ...

The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.

Danaher (NYSE:DHR) closed 2025 with what management described as a “strong finish” and better-than-expected performance across its portfolio, driven by continued strength in bioprocessing and ...

Q4 2025 Earnings Call January 28, 2026 8:00 AM ESTCompany ParticipantsJohn Bedford - Vice President of Investor ...

Danaher Corporation (NYSE:DHR) Q4 2025 Earnings Call Transcript January 28, 2026 Danaher Corporation beats earnings ...

The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only continuing operations and period-to-period ...

A research team led by La Trobe University has developed a single-use test strip that could ultimately change how diseases ...

A research team led by La Trobe University has developed a single-use test strip which could ultimately change how diseases like cancer are diagnosed. The research, published in the journal Small, ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, FDA-authorized PCR ...

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality Results Today, Visby Medical announced two new relationships that will expand national access to the Visby ...

“Infectious diseases don’t respect borders,” says Khoa Thai, a clinical microbiologist at the Star-shl medical diagnostics laboratory in the Netherlands. To limit their spread, we need a globally ...